Publication:
Tolerance and adherence of patients with chronic chagas disease treated with benznidazole

Simple item page
dc.contributor.authorVázquez, Cristina
dc.contributor.authorGarcía-Vázquez, Elisa
dc.contributor.authorCarrilero, Bartolomé
dc.contributor.authorSimón, Marina
dc.contributor.authorFranco, Fuensanta
dc.contributor.authorIborra, María Asunción
dc.contributor.authorGil-Gallardo, Luis Javier
dc.contributor.authorSegovia, Manuel
dc.contributor.departmentMedicina
dc.date.accessioned2024-06-19T10:35:00Z
dc.date.available2024-06-19T10:35:00Z
dc.date.issued2023
dc.description©2023 Sociedade Brasileira de Medicina Tropical. This manuscript version is made available under the CC-BY 4.0 license http://creativecommons.org/licenses/by-nc-nd/4.0/ . This document is the Published, version of a Published Work that appeared in final form in Journal of the Brazilian Society of Tropical Medicine . To access the final edited and published work see https://doi.org/10.1590/0037-8682-0384-2022es
dc.description.abstractBackground: Chagas disease (CD) treatment is commonly associated with a high incidence of adverse effects. It is crucial to study and update these adverse effects to improve the existing knowledge of which drugs to use and to clarify the information presented to patients. Methods: We analyzed the adverse effects of benznidazole in two cohorts of patients: a large retrospective study and a small prospective study. Results: This large retrospective study described the most and least common adverse effects in our area and characterized our Chagas disease population. This prospective study, along with a close follow-up of the treatment, detected more adverse effects and enhanced the patients’ perception of the disease and treatment. Conclusions: This information is important for preventing non-medical-related withdrawals and for removing baseless fears. Better knowledge of patients could help us provide better care.es
dc.formatapplication/pdfes
dc.format.extent8es
dc.identifier.citationJournal of the Brazilian Society of Tropical Medicine, Vol.:56 | (e0384-2022) | 2023
dc.identifier.doihttps://doi.org/10.1590/0037-8682-0384-2022
dc.identifier.urihttp://hdl.handle.net/10201/142439
dc.languageenges
dc.publisherSociedade Brasileira de Medicina Tropicales
dc.relationSin financiación externa a la Universidades
dc.relation.publisherversionhttps://www.scielo.br/j/rsbmt/a/WJtbS85YWJhDwh35BzTG5MD/?format=pdf&lang=enes
dc.rightsinfo:eu-repo/semantics/openAccesses
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 Internacional*
dc.rights.urihttp://creativecommons.org/licenses/by /4.0/*
dc.subjectChagases
dc.subjectBenznidazolees
dc.subjectTrypanosoma cruzies
dc.subjectTolerancees
dc.subjectAdherence.es
dc.titleTolerance and adherence of patients with chronic chagas disease treated with benznidazolees
dc.typeinfo:eu-repo/semantics/articlees
dspace.entity.typePublicationes
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
Tolerance and Adherence of Patients ....pdf
Size:
500.65 KB
Format:
Adobe Portable Document Format
Description:
Download
License bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
license.txt
Size:
2.26 KB
Format:
Item-specific license agreed upon to submission
Description:
Download
Collections
Artículos